Can Ficicioglu, MD, PhD

male silhouette icon
Can Ficicioglu, MD, PhD, is Director of the Newborn Metabolic Screening Program and the Lysosomal Storage Diseases Program, and Clinical Director of the Metabolic Disease Program at Children's Hospital of Philadelphia.

Areas of Expertise: Fatty acid oxidation defects, Galactosemia, Lysosomal Storage Disorders, Newborn metabolic screening, Phenylketonuria (PKU), Metabolic genetic disorders, Pediatric clinical genetics
Locations: Main Hospital

Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Medical School

University of Istanbul, Cerrahpasa Medical School, Istanbul, Turkey


University of Istanbul, Cerrahpasa Medical School


Albert Einstein Medical College, Montefiore Hospital and Medical Center, New York Medical College and St. Vincent's Catholic Medical Center, New York, N.Y.


Harvard Medical School and Children's Hospital Boston, Boston, Mass.

Board Certification

Clinical Biochemical Genetics – American Board of Medical Genetics and Genomics
Pediatrics – American Board of Pediatrics

Titles and Academic Titles

Director, Newborn Metabolic Screening Program

Director, Lysosomal Storage Diseases Program

Clinical Director, Metabolic Disease Program

Principal Investigators

Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Conditions Treated

Departments and Services




Ficicioglu C, Hussa C, Gallagher PR, Thomas N, Yager C. Monitoring of biochemical status in children with Duarte galactosemia: utility of galactose, galactitol, galactonate, and galactose 1-phosphate. Clin Chem. 2010 Jul;56(7):1177-82. Epub 2010 May 20.

Freer DE, Ficicioglu C, Finegold D. Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach. Clin Chem. 2010 Mar;56(3):437-44. Epub 2010 Jan 14.

Ficicioglu C, An Haack K. Failure to thrive: when to suspect inborn errors of metabolism. Pediatrics. 2009 Sep;124(3):972-9. Epub 2009 Aug 10.

Arnold GL, Van Hove J, Freedenberg D, Strauss A, Longo N, Burton B, Garganta C, Ficicioglu C, Cederbaum S, Harding C, Boles RG, Matern D, Chakraborty P, Feigenbaum A. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2009 Mar;96(3):85-90. Epub 2009 Jan 20.

Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010 Mar;156(3):492-4. Epub 2010 Jan 8.

Coughlin CR 2nd, Ficicioglu C. Genotype-phenotype correlations: sudden death in an infant with very-long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2010 Jan 27. [Epub ahead of print]

Awards and Honors

2022, Philadelphia Magazine's Top Doctors in Clinical Genetics